SAGA Diagnostics
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $12M
Investors
- 3
About SAGA Diagnostics
a. SAGA Diagnostics operates as a personalized cancer medicine and disease monitoring company that commercializes proprietary technologies to quantify cancer-associated genetic aberrations in tissue and liquid biopsy samples.001% mutant allele fraction. As of January 2023, Peter Collins is the CEO of the company. SAGA Diagnostics provides ultrasensitive services and products to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally invasive liquid biopsy cancer testing services and kits. The company’s proprietary tests help oncologists, patients, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.001% mutant allele frequency (MAF); SAGASIGN, a hybrid method that monitors responses to therapy, MRD (minimal residual disease), and recurrences; and SAGASEQ, a third platform technology for enhanced sequencing library preparation together with AI/machine learning bioinformatics to reduce sequencing noise and increase true-positive signal. As of January 2023, the firm is engaged in research-oriented studies in breast cancer, prostate cancer, melanoma, colorectal cancer, lung cancer, ovarian cancer, and AML.
Who invested in SAGA Diagnostics
3 investors across 1 round
See all investors in SAGA Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 29, 2021
Amount
$12M
Investors
Questions about SAGA Diagnostics
Who invested in SAGA Diagnostics?
SAGA Diagnostics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SAGA Diagnostics raised?
SAGA Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SAGA Diagnostics last raise money?
SAGA Diagnostics's most recent round on record is a Series A, in Jun 2021.
What does SAGA Diagnostics do?
SAGA Diagnostics is a biotechnology company.
Where is SAGA Diagnostics headquartered?
SAGA Diagnostics is headquartered in Lund, Sweden.
Which VCs invest in companies like SAGA Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SAGA Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SAGA Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.